You are viewing: US Biosurgery Market analysis
Part of: Biosurgery Market (Global)

The US Biosurgery Market was valued at $5338.2 Million in 2025 and projected to reach to $6936 Million by 2030, representing a compound annual growth rate of 5.4%. The US biosurgery market is poised for steady growth through 2030, driven by increasing surgical volumes, aging population demographics, and rising adoption of minimally invasive procedures.

US Biosurgery Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Biosurgery Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high surgical volumes, and strong adoption of innovative biosurgical products across hospitals and surgical centers.
  • Driving this expansion in the US are increasing surgical procedures, rising demand for hemostatic agents, and growing preference for minimally invasive techniques that reduce patient recovery times. In the US, biosurgery encompasses hemostats, sealants, adhesion barriers, and regenerative products that enhance surgical outcomes and reduce complications.
  • The US market is characterized by significant investment in research and development, robust reimbursement frameworks, and a competitive landscape dominated by established medical device manufacturers.
  • Between 2025 and 2030, the US biosurgery sector is expected to experience steady growth driven by aging demographics, increased prevalence of chronic diseases requiring surgical intervention, and continuous innovation in product formulations and delivery mechanisms..

Key Market Statistics

  • CAGR (2025-2030) 5.4% CAGR
  • Market Size, 2025 ~USD 5338.2 Million
  • Forecast, 2030 ~USD 6936 Million
  • Country US

US Biosurgery Market Overview

Market Size & Growth :

The US biosurgery market is valued at $5,338.2 million in 2025 and is projected to reach $6,936 million by 2030, growing at a CAGR of 5.4%, outpacing many developed markets.

Advanced Healthcare Infrastructure :

The US benefits from state-of-the-art surgical facilities, high adoption rates of innovative biosurgical technologies, and strong reimbursement frameworks that accelerate market penetration.

High Surgical Volume :

With millions of surgical procedures performed annually across hospitals and surgical centers, the US maintains consistent demand for biosurgical products and hemostatic solutions.

Innovation & Product Development :

Leading medical device manufacturers prioritize the US market for new biosurgery product launches, driven by regulatory clarity, strong IP protection, and premium pricing capabilities.

US Biosurgery Market Dynamics

  • Healthcare providers continue to invest in advanced hemostatic and tissue sealing solutions to improve patient outcomes and reduce operative complications.
  • Reimbursement support and clinical evidence backing biosurgical products strengthen market expansion.
  • The competitive landscape remains dynamic with both established players and emerging innovators launching next-generation solutions tailored to US surgical specialties..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • The US biosurgery market is valued at $5,338.2 million in 2025 and will reach $6,936 million by 2030 at a 5.4% CAGR.
    • The US market is driven by high surgical volumes, advanced healthcare infrastructure, and strong adoption of innovative biosurgical solutions.
    • Aging demographics and increased chronic disease prevalence in the US are key growth catalysts for biosurgery demand through 2030.
    • The US biosurgery sector is characterized by robust reimbursement, significant R&D investment, and competition among established medical device manufacturers.

    Biosurgery Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BONE MORPHOGENETIC PROTEINS (Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 6.4% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 15.83 (2025)
    Revenue Forecast (Billions) ~USD 21.59 (2030)
    Segments Covered Type, Origin, Application, End User, Product

    US Biosurgery Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Type

    • Albumin-Based Sealants & Adhesives
    • Allografts
    • Biological Meshes
    • Bone Morphogenetic Proteins
    • Collagen & Protein Adhesion Barriers
    • Collagen-Based Sealants & Adhesives
    • Combination Hemostatic Agents
    • Cyanoacrylate-Based Sealants & Adhesives
    • Demineralized Bone Matrix
    • Fibrin-Based Adhesion Barriers
    • Fibrin-Based Sealants & Adhesives
    • Gelatin-Based Sealants & Adhesives
    • Hyaluronic Acid-Based Adhesion Barriers
    • Natural Adhesion Barriers
    • Natural/Biological Sealants & Adhesives
    • Natural/Biological Surgical Sealants & Adhesives
    • Other Bone-Graft Substitutes
    • Other Natural/Biological Surgical Sealants & Adhesives
    • Other Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Other Synthetic Adhesion Barriers
    • Oxidized Regenerated Cellulose-Based Hemostatic Agents
    • Peg Hydrogel-Based Sealants & Adhesives
    • Peg-Based Adhesion Barriers
    • Regenerated Cellulose-Based Adhesion Barriers
    • Synthetic & Semi-Synthetic Surgical Sealants & Adhesives
    • Synthetic Adhesion Barriers
    • Synthetic Bone Grafts
    • Synthetic Meshes
    • Thrombin-Based Hemostatic Agents
    • Urethane-Based Sealants & Adhesives
    • Xenografts

    By Origin

    • Animal-Based Sealants & Adhesives
    • Human Blood-Based Sealants & Adhesives

    By Application

    • Cardiovascular Surgery
    • General Surgery
    • Gynecological Surgery
    • Neurological Surgery
    • Orthopedic Surgery
    • Other Applications
    • Reconstructive Surgery
    • Thoracic Surgery
    • Urological Surgery

    By End User

    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
    • Other End Users

    By Product

    • Adhesion Barriers
    • Bone-Graft Substitutes
    • Hemostatic Agents
    • Soft-Tissue Attachments
    • Staple-Line Reinforcement Agents
    • Surgical Sealants & Adhesives

    Target Audience

    • Medical Device Manufacturers : Biosurgery companies need US-specific market data to develop targeted product strategies, identify market gaps, and optimize commercial operations in the world's largest healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed US market forecasts and growth drivers to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities.
    • Hospital & Surgical Center Administrators : Healthcare facility leaders use market insights to make informed procurement decisions, evaluate biosurgical product options, and optimize surgical supply chain management.
    • Market Research & Strategy Consultants : Consulting firms leverage US biosurgery market data to support client engagements, competitive analyses, and strategic planning initiatives across the healthcare sector.
    • Regulatory & Compliance Professionals : Regulatory specialists and quality assurance teams need market context to understand competitive landscape, reimbursement requirements, and compliance standards specific to US operations.

    Reasons to Buy this Report

    • Accurate US Market Sizing : Obtain precise market valuations and forecasts specific to the United States, enabling confident investment and resource allocation decisions in this high-value healthcare segment.
    • Competitive Intelligence : Identify leading biosurgery manufacturers, their market share, product portfolios, and strategic positioning within the US market to benchmark against competitors.
    • Growth Driver Analysis : Understand key factors propelling the 5.4% CAGR in the US, including surgical volume trends, reimbursement dynamics, and adoption of innovative hemostatic solutions.
    • Regulatory & Reimbursement Insights : Gain clarity on FDA approval pathways, Medicare/insurance coverage policies, and reimbursement trends that directly impact market accessibility and profitability in the US.
    • Strategic Market Opportunities : Identify high-growth surgical specialties, underserved segments, and emerging applications within the US biosurgery market to guide product development and go-to-market strategies.

    Frequently asked questions

    What is the current size of the US biosurgery market in 2025?

    The US biosurgery market is estimated at $5,338.2 million in 2025.

    What is the projected size of the US biosurgery market by 2030?

    The US biosurgery market is projected to reach $6,936 million by 2030.

    What is the growth rate of the US biosurgery market?

    The US biosurgery market is expected to grow at a compound annual growth rate of 5.4% from 2025 to 2030.

    What products are included in the US biosurgery market?

    The US biosurgery market includes hemostats, sealants, adhesion barriers, and regenerative products used to enhance surgical outcomes.

    What factors are driving growth in the US biosurgery market?

    Key growth drivers in the US include aging demographics, increased surgical volumes, rising chronic disease prevalence, and growing adoption of minimally invasive surgical techniques.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Biosurgery Market

    *C-level primaries include CEOs, CFOs, COOs, and VPs.

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

    Source: MarketsandMarkets Analysis

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of various biosurgery manufacturers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from biosurgery (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global biosurgery market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    Market Size Estimation (Bottom-up Approach and Top-down Approach)

    Biosurgery Market

    Data Triangulation

    After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

    Market Definition

    Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.

    Stakeholders

    • Transfection products manufacturing companies
    • Pharmaceutical & Biopharmaceutical Companies
    • Chemical Companies
    • Biopharmaceutical Companies
    • Contract Research Organizations (CROs)
    • Contract Development and Manufacturing Organizations (CDMOs)
    • Research Institutes and Universities 
    • Venture Capitalists & Investors
    • Government Associations

    Report Objectives

    • To define, describe, segment, and forecast the transfection technologies market by product type, method, application, end user, and region
    • To provide detailed information about the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the transfection technologies market in five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, along with their respective key countries
    • To profile the key players in the transfection technologies market and comprehensively analyze their core competencies2 and market shares
    • To track and analyze competitive developments, such as product launches, acquisitions, expansions, collaborations, agreements, and partnerships of the leading players in the transfection technologies market
    • To benchmark players within the transfection technologies market using the ‘Competitive Leadership Mapping’ framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share/rank

    Get the Full Biosurgery Market Report

    Full forecast, segment splits, and company analysis for all Biosurgery Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status